European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group
European Journal of Endocrinology · 2025
DOI: 10.1093/ejendo/lvaf239 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Endocrinology, 2025. Verfasst von Michaela Kuhlen und 23 weiteren Autor:innen. Beteiligte Einrichtung: Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Augsburg 86156, Germany. Hauptthemen laut MEDLINE: Adrenal Gland Neoplasms, Paraganglioma, Extra-Adrenal, Practice Guidelines as Topic, Paraganglioma. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: German Childhood Cancer Foundation, Fondazione Giovanni Celeghin.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Adrenal (formerly termed pheochromocytomas) and extra-adrenal paragangliomas (PGLs) in children and adolescents are rare neuroendocrine tumors characterized by unique biological behavior, a strong hereditary component, and significant risk of recurrence and metastatic progression. Their management requires specialized, multidisciplinary care.
Objective
This guidance provides harmonized, evidence-graded recommendations for the diagnosis, treatment, and follow-up of pediatric PGL, developed by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) as part of the European Standard Clinical Practice (ESCP) initiative.
Methods
Recommendations were formulated through structured consensus by a multidisciplinary panel of experts in pediatric oncology, endocrinology, surgery, nuclear medicine, genetics, and pathology, based on literature review, existing international guidelines, and integration of external adviser feedback. Levels of evidence and grades of recommendation follow a simplified GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system. Recommendations Diagnosis should be based on plasma-free metanephrine and normetanephrine as first-line test, complemented by appropriate anatomical and functional imaging guided by biochemical phenotype and genotype. Germline genetic testing is recommended. Tumor resection remains the mainstay of curative treatment, with cortical-sparing adrenalectomy advised in bilateral hereditary cases (except SDHB). Management of metastatic disease should be individualized, incorporating radionuclide therapy, systemic treatments, focal therapies, and palliative care as appropriate. Lifelong surveillance is essential, tailored to genotype and disease characteristics.
Conclusion
This European clinical guidance offers practical recommendations to support multidisciplinary management of pediatric PGL within European healthcare systems, complementing existing international consensus statements and supporting harmonization of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatrics and Adolescent Medicine, Faculty of Medicine, University of Augsburg, Augsburg 86156, Germany.
- Bavarian Cancer Research Center (BZKF), Augsburg 86156, Germany.
- Department of Woman and Child's Health, University Padua, Padua 35128, Italy.
- Pediatric Surgery Unit, University Hospital of Padua, Padua 35121, Italy.
- Department of Pediatric and Adolescents Oncology, Gustave Roussy Cancer Institute, Paris Saclay University, Villejuif 94800, France.
- Department of Pediatric Visceral and Neonatal Surgery, Sorbonne University, Armand-Trousseau Children's Hospital, APHP, Paris 75012, France.
ORCID-Profile: Michaela Kuhlen, Christina Pamporaki, Andrea Ferrari, Constantin Lapa, Antje Redlich, Daniel Orbach
Förderung
- German Childhood Cancer Foundation
- Fondazione Giovanni Celeghin
Zitieren
APA
Kuhlen, M., Virgone, C., Rigaud, C., Irtan, S., Casey, R., Pamporaki, C., Kunstreich, M., Lopez-Almara, R., Ben-Ami, T., Bien, E., Krawczyk, M. A., Mazic Cesen, M., Ferrari, A., Bisogno, G., Reguerre, Y., Abele, M., Schneider, D. T., Fuchs, J., Brecht, I. B., …, & Orbach, D. (2025). European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group. European Journal of Endocrinology. https://doi.org/10.1093/ejendo/lvaf239
Vancouver
Kuhlen M, Virgone C, Rigaud C, Irtan S, Casey R, Pamporaki C, et al. European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group. European Journal of Endocrinology. 2025. doi:10.1093/ejendo/lvaf239
BibTeX
@article{Kuhlen2025,
author = {Kuhlen, Michaela and Virgone, Calogero and Rigaud, Charlotte and Irtan, Sabine and Casey, Ruth and Pamporaki, Christina and Kunstreich, Marina and Lopez-Almara, Ricardo and Ben-Ami, Tal and Bien, Ewa and Krawczyk, Malgorzata A and Mazic Cesen, Maja and Ferrari, Andrea and Bisogno, Gianni and Reguerre, Yves and Abele, Michael and Schneider, Dominik T and Fuchs, Jörg and Brecht, Ines B and Timmermann, Beate and de Krijger, Ronald R and Lapa, Constantin and Redlich, Antje and Orbach, Daniel},
title = {European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group},
journal = {European Journal of Endocrinology},
year = {2025},
doi = {10.1093/ejendo/lvaf239}
}
EUVIMED